Models:
Joseph Gordon
joseph-gordon/
ClinicalTrialsElig
0
Downloads: 1
[c09aa8]: / clusters / ordered9kclusters / clust_1466.txt

Download this file

273 lines (272 with data), 10.5 kB 

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
Adequate organ function

Adequate organ function

Adequate major organ function

Have adequate organ function.

Adequate organ function

Demonstrated adequate organ function within 14 days of Cycle 1 Day 1 (C1D1).

Has adequate organ function

Adequate organ function

Demonstrate adequate organ function as evidenced by laboratory testing

Has adequate organ function.

Adequate organ function at baseline .

Patient must meet the organ function and system function requirements as stated in the protocol

Adequate organ function as measured by various blood parameters

Have adequate organ function.

Demonstrates adequate organ function

Adequate organ function.

Adequate organ function

Adequate organ function

Have adequate organ function

Adequate organ function

Have adequate organ function, including:

Have adequate organ function.

Have adequate organ function.

Adequate organ function

Poor organ function.

Demonstrates adequate organ function.

Adequate organ function.

Good organ function:

Must have adequate organ function.

Demonstrates adequate organ function.

Adequate organ function

Adequate organ function

Has adequate organ function

Have adequate organ function.

Has adequate organ function.

The patient has adequate baseline organ function, as demonstrated by the following:

Organ Function Requirements:

Adequate organ function within 14 days of study registration including:\r\n* Platelets >= 100 x 10^9/L

Adequate organ function within 14 days of study registration including:\r\n* Hemoglobin >= 8 g/dL

Organ function:

Subjects with adequate organ function as measured by:

adequate organ function

Adequate organ system function.

Patients must have adequate major organ function and meet the following criteria:

Demonstrate adequate organ function

Adequate organ function

Adequate baseline organ function within 14 days prior to the first dose of enzalutamide and/or CORT125281

ORGAN FUNCTION AND PERFORMANCE STATUS CRITERIA:

Adequate organ function at screening

Has adequate organ function

Has adequate organ function within 7 days before enrollment

Adequate organ function

-  Has adequate organ function.

Demonstrate adequate organ function

Adequate organ system function.

Have adequate organ function.

Evidence of insufficient organ function as determined by the protocol.

Candidate for pembrolizumab (as determined by physician, and adequate organ function)

Adequate organ function.

HEALTHY SUBJECT: Have adequate organ function

Adequate organ function.

Adequate organ function confirmed at Screening and within 10 days of initiating treatment, as evidenced by:

Adequate organ function within 14 days of study registration

Adequate organ function.

Patient has adequate organ function at Baseline

Adequate organ and neurologic function

Has adequate organ function including:

Adequate organ function

Have adequate organ function.

Adequate organ function

Have adequate organ function.

Potentially eligible for reduced intensity conditioning based on known organ function (formal organ function testing may occur after consent)

Have adequate organ function.

Adequate organ function

Organ function:

Patients must have adequate organ function

Adequate organ function within 14 days of registration

Adequate organ function

Acceptable end-organ function, except for documented exclusions for organ function compromise due to ALL itself

Adequate organ function

Organ Function Requirements:

Adequate organ function as outlined below (unless due to leukemia)

Adequate organ function

Adequate organ function including:

Adequate organ function

All organ function testing should be done within 28 days of study registration

Have adequate organ function.

Adequate organ function.

Adequate organ function

Patient has adequate organ function

Patients must have adequate organ function

Adequate organ system function within 14 days of baseline:

Poor organ function.

Has adequate organ function

Adequate organ function

Adequate organ function

Organ function characterized by ? Grade 1

Have adequate organ function

Patients must have adequate organ and system function.

Organ function must be adequate as follows:

Has adequate organ function

Adequate organ function.

Adequate organ function

Patient must meet the organ function and system function requirements as stated in the protocol

Adequate organ function as evidenced by:

Adequate organ function

-  The participant has adequate organ function:

Demonstrates adequate organ function.

Adequate organ function.

Adequate organ function

Demonstrates adequate organ function.

adequate organ function

Adequate organ function

Adequate organ function

Adequate organ function:

Adequate organ function prior to registration

Adequate organ function

Adequate organ function

Adequate organ function

Demonstrates adequate organ function

Demonstrates adequate organ function.

Adequate organ function

Has adequate organ function

Have adequate organ function.

Adequate organ function as shown by:

Hemodynamically stable and adequate organ function

Poor organ function.

Adequate organ function

Adequate organ function.

Demonstrates adequate organ function.

Adequate organ function

Adequate organ function

Adequate organ function

Chemistry panel obtained 30 days prior to registration on study, with adequate organ function

Have adequate organ function.

Adequate organ function

Adequate organ function

Has adequate organ function.

Patients must have adequate organ function:

Must have adequate organ function as demonstrated by the following:

Adequate Organ Function

have adequate organ function

Adequate organ function

Have adequate organ function.

Demonstrates adequate organ function

Has adequate organ function

Organ Function

Demonstrate adequate organ function as detailed above

Have adequate organ function.

Adequate organ function

Have adequate organ function

Adequate baseline organ function.

Adequate organ function

Adequate organ function

Have adequate organ function including:

Have adequate organ function

Adequate baseline organ function, as demonstrated by the following:

Adequate organ function

Demonstrated adequate organ function within 14 days of treatment initiation.

Have adequate organ function.

Has adequate organ function

Adequate organ function

Adequate organ function including:

Adequate organ function

Adequate organ function.

Adequate organ function

The participant has adequate organ function.

The participant has adequate organ function, including:

Subject has adequate organ function.

Adequate organ function

Adequate organ function

Adequate organ function

Adequate organ function

Adequate organ function

Adequate organ function

Adequate organ function

Adequate organ function

Adequate organ function

Adequate organ function

Adequate organ function including:

Adequate organ function

Adequate organ function within 14 days of dosing

Adequate organ function

Has adequate organ function

Adequate major organ system function

Adequate organ function including:

Adequate organ function including:

Have adequate organ function;

Adequate organ function

Adequate baseline organ function

Have adequate organ system function

Patients with adequate organ function as measured by:

Adequate organ function

Has adequate organ function

The participant has adequate organ function.

Adequate organ function as evidenced by the following laboratory findings:

Adequate organ function within 10 days of Day 1

Has adequate organ function

Demonstrates adequate organ function.

Adequate baseline organ function.

Adequate organ function within 3 weeks prior to first study drug administration as evidenced by:

Adequate organ function per blood work

Adequate organ function

Adequate organ function as shown by:

Adequate baseline organ function

Have adequate organ function

Subject has adequate organ function.

Adequate organ function

Adequate organ function.

Adequate organ function including:

Has adequate organ function, before the first dose of study drug.

Adequate organ function.

Adequate organ function including the following:

Adequate organ system function.

Adequate organ function

Adequate organ function

Demonstrate adequate organ function.

Adequate organ function

Acceptable organ function as evidenced by the following:

Adequate organ function.

Have adequate organ function.

Have adequate organ function.

Have adequate organ function.

Adequate organ function as determined by the following laboratory results, within 28\n             days prior to randomization

Adequate organ function within 14 days of study entry

Adequate organ function

Adequate organ function at baseline:

Have adequate organ function.

Adequate organ function

Adequate organ function, including the following:

Adequate organ function:

Adequate organ function including:

Adequate baseline organ function.

Adequate organ function

Adequate organ function

Organ function </= grade 1.

Adequate organ function

Adequate organ function;

Adequate organ function

Adequate organ system function determined within 14 days prior to first dose of study treatment.

Adequate organ function.

At the time of the CMV specific T cell infusion, the recipient must have adequate organ function as indicated by < grade 3 across all organ systems except for hematologic toxicity

Have adequate organ function, including:

Adequate organ function.

Adequate organ system function.

Patients with adequate organ function as measured by:

Has adequate organ function as determined by laboratory tests

adequate organ function

Adequate organ function, including the following:

Adequate other organ function at screening and enrollment.

Adequate other organ function at screening and enrollment.

Participants must have adequate organ function, including the following:

Life expectancy of at least 12 weeks. - Adequate organ function

All organ function testing should be done within 28 days of study registration

Adequate organ function

Adequate organ function including:

Has adequate organ function.

Has adequate organ function

Adequate organ function including:

Adequate baseline organ function:

Have adequate organ function

Adequate organ function

Organ function requirements:

Adequate organ function determined within 14 days prior to enrollment

Adequate organ function.

Must have adequate organ function, including the following:

Adequate organ function as determined by the investigator

Demonstrates adequate organ function, within 10 days prior to the start of study drug.

Adequate organ function as per protocol.

Has adequate organ function

Adequate organ function

Evidence of adequate organ function by standard laboratory tests.